Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29620230 | 1.00 | TSHR (0.53) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL29620231 | 1.00 | TSHR (0.53) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL14375347 | 0.85 | ALDH1A1 (0.57) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL5615235 | 0.83 | CYP1A2 (0.52) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL24777598 | 0.81 | CYP1A2 (0.42) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL4961619 | 0.81 | TSHR (0.54) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL2696664 | 0.81 | CYP1A2 (0.42) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL21515603 | 0.81 | CYP1A2 (0.42) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL20356034 | 0.81 | CYP2A6 (0.50) | TSHRALDH1A1CYP1A2HSD17B10HPGD | |
| SCHEMBL14375274 | 0.81 | AHR (0.42) | TSHRALDH1A1CYP1A2HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250349904-A1 | SOLID-STATE BATTERY CELL ASSEMBLY AND PREPARATION METHOD THEREFOR, BATTERY, AND APPLICATION THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2025-11-13 | — | — | US | claimed |
| EP-4632931-A1 | SOLID-STATE BATTERY CELL ASSEMBLY AND PREPARATION METHOD THEREFOR, AND BATTERY AND APPLICATION THEREOF | Contemporary Amperex Technology Co., Limited (CN) | 2025-10-15 | — | — | EP | claimed |
| WO-2024206445-A9 | METHODS AND SYSTEMS FOR NANOBUBBLE GENERATION AND USE | UNIVERSITY OF MAINE SYSTEM BOARD OF TRUSTEES (US) | 2025-04-10 | — | — | WO | claimed |
| CN-119161908-A | Production process for preparing pyridine-rich biological oil by pretreatment biomass classification-nitrogen-rich pyrolysis | 山东理工大学 | 2024-12-20 | — | — | CN | claimed |
| CN-118801043-A | Solid-state battery cell assembly, preparation method thereof, battery and application thereof | 宁德时代新能源科技股份有限公司 | 2024-10-18 | — | — | CN | claimed |
| WO-2024212528-A1 | SOLID-STATE BATTERY CELL ASSEMBLY AND PREPARATION METHOD THEREFOR, AND BATTERY AND APPLICATION THEREOF | 宁德时代新能源科技股份有限公司 | 2024-10-17 | — | — | WO | claimed |
| WO-2024206445-A2 | METHODS AND SYSTEMS FOR NANOBUBBLE GENERATION AND USE | UNIVERSITY OF MAINE SYSTEM BOARD OF TRUSTEES (US) | 2024-10-03 | — | — | WO | claimed |
| CN-114583392-B | Slurry of metal-organic framework material-based heat-resistant flame-retardant film, and preparation method and application thereof | 广东工业大学 | 2024-09-13 | — | — | CN | claimed |
| CN-114773220-B | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-114773220-A | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-110767464-B | Super capacitor containing MOFs material and preparation method thereof | 东莞东阳光科研发有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114583392-A | Slurry of metal-organic framework material-based heat-resistant flame-retardant film and preparation method and application thereof | 广东工业大学 | 2022-06-03 | — | — | CN | claimed |
| CN-104817697-B | A kind of branched polyphenylene sulfide copolymer and preparation method thereof containing condensed-nuclei aromatics | 常州大学 | 2018-10-19 | — | — | CN | claimed |
| CN-104817697-A | Branched polyphenylene sulfide copolymer containing polycyclic aromatic hydrocarbon, and preparation method thereof | UNIV CHANGZHOU | 2015-08-05 | — | — | CN | claimed |
| US-20250349904-A1 | SOLID-STATE BATTERY CELL ASSEMBLY AND PREPARATION METHOD THEREFOR, BATTERY, AND APPLICATION THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2025-11-13 | — | — | US | disclosed |
| EP-4632931-A1 | SOLID-STATE BATTERY CELL ASSEMBLY AND PREPARATION METHOD THEREFOR, AND BATTERY AND APPLICATION THEREOF | Contemporary Amperex Technology Co., Limited (CN) | 2025-10-15 | — | — | EP | disclosed |
| US-20250154156-A1 | QUINAZOLINE DERIVATIVE AS KRAS G12C MUTATION INHIBITOR | SHENZHEN FORWARD PHARMACEUTICALS CO., LIMITED (CN) | 2025-05-15 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154156-A1 | QUINAZOLINE DERIVATIVE AS KRAS G12C MUTATION INHIBITOR | KRAS, NRAS, HRAS | TSHR 4500/4885ALDH1A1 1724/4885CYP1A2 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.